Maria Sjölander1,2, Marie Eriksson2, Eva-Lotta Glader3. 1. Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden. 2. Department of Statistics, Umeå University, Umeå, Sweden. 3. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Abstract
INTRODUCTION: The objective was to investigate differences in adherence to statins after stroke based on age, sex, socioeconomic status and country of birth. PATIENTS AND METHODS: Patients with ischemic stroke in 2009-2010 were included from the Swedish stroke register. Adherence to statin treatment was measured over two years as proportion of days covered with 80% as cut-off for adherence. Income, education, and country of birth were obtained from official registers. Factors associated with adherence were controlled for in multivariable logistic regression. RESULTS: Of 15,192 included patients, 73.9% had an adherence rate ≥80%. The oldest (85+ years) and youngest (18-54 years) had the lowest adherence, and a smaller proportion of women were adherent (odds ratio (OR) 0.84; 95% confidence interval (CI) 0.77-0.92). Adherence was less common in patients born in Nordic countries (OR 0.82; 95% CI (0.68-0.97), Europe (OR 0.78; 95% CI 0.65-0.93), and in non-European countries (OR 0.65; 95% CI 0.50-0.84) compared to Sweden-born. Patients with university education were to a lower extent adherent compared to patients with primary school education (OR 0.81; 95% CI 0.72-0.91). There was no association between adherence and income. DISCUSSION: The study was based on individual level real-life data with national coverage. Adherence was estimated from data on filled prescriptions, but filled prescription does not mean that drugs are used as intended. CONCLUSION: Adherence to statin treatment over two years was suboptimal, and adherence was less common among women, patients born outside of Sweden and patients with university education.
INTRODUCTION: The objective was to investigate differences in adherence to statins after stroke based on age, sex, socioeconomic status and country of birth. PATIENTS AND METHODS: Patients with ischemic stroke in 2009-2010 were included from the Swedish stroke register. Adherence to statin treatment was measured over two years as proportion of days covered with 80% as cut-off for adherence. Income, education, and country of birth were obtained from official registers. Factors associated with adherence were controlled for in multivariable logistic regression. RESULTS: Of 15,192 included patients, 73.9% had an adherence rate ≥80%. The oldest (85+ years) and youngest (18-54 years) had the lowest adherence, and a smaller proportion of women were adherent (odds ratio (OR) 0.84; 95% confidence interval (CI) 0.77-0.92). Adherence was less common in patients born in Nordic countries (OR 0.82; 95% CI (0.68-0.97), Europe (OR 0.78; 95% CI 0.65-0.93), and in non-European countries (OR 0.65; 95% CI 0.50-0.84) compared to Sweden-born. Patients with university education were to a lower extent adherent compared to patients with primary school education (OR 0.81; 95% CI 0.72-0.91). There was no association between adherence and income. DISCUSSION: The study was based on individual level real-life data with national coverage. Adherence was estimated from data on filled prescriptions, but filled prescription does not mean that drugs are used as intended. CONCLUSION: Adherence to statin treatment over two years was suboptimal, and adherence was less common among women, patients born outside of Sweden and patients with university education.
Authors: Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245
Authors: Björn Wettermark; Niklas Hammar; Carl Michael Fored; C MichaelFored; Andrejs Leimanis; Petra Otterblad Olausson; Ulf Bergman; Ingemar Persson; Anders Sundström; Barbro Westerholm; Måns Rosén Journal: Pharmacoepidemiol Drug Saf Date: 2007-07 Impact factor: 2.890
Authors: Pierre Amarenco; Larry B Goldstein; Michael Szarek; Henrik Sillesen; Amy E Rudolph; Alfred Callahan; Michael Hennerici; Lisa Simunovic; Justin A Zivin; K Michael A Welch Journal: Stroke Date: 2007-10-25 Impact factor: 7.914
Authors: Georg Hans Kuhn; Frederick R Walker; Michael Nilsson; Madeleine Hinwood; Jenny Nyberg; Lucy Leigh; Sara Gustavsson; John Attia; Christopher Oldmeadow; Marina Ilicic; Thomas Linden; N David Åberg; Chris Levi; Neil Spratt; Leeanne M Carey; Michael Pollack; Sarah J Johnson Journal: BMJ Open Date: 2022-05-09 Impact factor: 3.006
Authors: Lachlan L Dalli; Monique F Kilkenny; Isabelle Arnet; Frank M Sanfilippo; Doyle M Cummings; Moira K Kapral; Joosup Kim; Jan Cameron; Kevin Y Yap; Melanie Greenland; Dominique A Cadilhac Journal: Br J Clin Pharmacol Date: 2022-05-22 Impact factor: 3.716
Authors: Susanne J Nielsen; Martin Karlsson; Erik Björklund; Andreas Martinsson; Emma C Hansson; Carl Johan Malm; Aldina Pivodic; Anders Jeppsson Journal: J Am Heart Assoc Date: 2020-03-02 Impact factor: 5.501